T0	Interventions 0 9	Ganitumab
T1	Interventions 22 32	exemestane
T2	Interventions 36 47	fulvestrant
T3	Interventions 323 332	Ganitumab
T4	Interventions 828 1063	intravenous ganitumab 12 mg per kg bodyweight or placebo in combination with open-label intramuscular fulvestrant (500 mg on day 1, then 250 mg on days 15, 29, and every 28 days) or oral exemestane (25 mg once daily) on a 28-day cycle.
T5	Interventions 1164 1200	Response was assessed every 8 weeks.
T6	Interventions 1491 1500	ganitumab
T7	Interventions 1611 1620	ganitumab
T8	Interventions 1779 1789	in the the
T9	Interventions 2054 2065	patients in
T10	Interventions 2438 2461	INTERPRETATION Addition